Latest News
Conference Coverage
DOAC’s edge over warfarin fades with low adherence
BOSTON –
Conference Coverage
Four phase 3 studies highlighted at ASCO mark progress in GI cancers
Prodige 7 addressed a long-unanswered question about the value of HIPEC and demonstrated that less is more when it comes to the treatment of...
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Conference Coverage
Youth with rhabdomyosarcoma see better survival with maintenance chemo
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
Latest News
DOJ won’t defend ACA from lawsuit challenging constitutionality
The outcome of a pending lawsuit could have a major impact on health care coverage in the United States.
News
FDA grants regular approval to venetoclax for CLL/SLL
The drug is indicated for patients with CLL or SLL, with or without 17p deletion, who have had at least one prior therapy.
Conference Coverage
Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL
CHICAGO – The drug combination was evaluated in a phase 2 study of patients with previously untreated CLL.
Conference Coverage
New cell-free DNA assays hold promise for lung cancer screening
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and...
Conference Coverage
Everolimus/exemestane improves PFS of ER+/HER2– breast cancer vs. everolimus alone
In this phase 2 randomized study, adding exemestane had better efficacy than did single-agent everolimus, but single-agent capecitabine appeared...
News from the FDA/CDC
FDA approves long-acting ESA for dialysis-related anemia in children, adolescents
Mircera is now indicated for dialysis-related anemia in patients aged 5-17 years with chronic kidney disease.
Feature
COA files lawsuit over budget sequestration
The Budget Control Act of 2011 put a 2% sequestration on the federal budget, which has the effect of lowering Part B drug reimbursement from...